GSK has been helping to prevent viral hepatitis around the world for over 30 years with Engerix-B, Havrix and Twinrix vaccines. We are also committed to researching new vaccines and treatments for chronic hepatitis B through technology compounds which can potentially provide a functional cure.
World Hepatitis Day would like to thank our supporters. To find out more about sponsoring World Hepatitis Day please email firstname.lastname@example.org
Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation’s (NYSE: DHR) Diagnostics platform. Cepheid is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated molecular diagnostic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.
For more information on other supporters of the World Hepatitis Alliance which delivers this website, visit www.worldhepatitisalliance.org